Gilde Healthcare, a leading specialized healthcare investor, today announced that its portfolio company Noema Pharma, has raised an oversubscribed CHF 103 million ($112 million) Series B financing round from new and existing investors. Noema Pharma is a clinical-stage biopharma company targeting debilitating central nervous system (CNS) disorders. The financing round was completed by an international syndicate led by new investors...
7 maart 2023
Gilde Healthcare company Synexa Life Sciences celebrates its 20th anniversary
Two decades of advancing drug development programs through specialist biomarker and bioanalytical insights Synexa Life Sciences, a specialist biomarker and bioanalysis services provider, celebrates its 20th anniversary on March the 3rd 2023. Since its inception in 2003, Synexa Life Sciences has become a trusted partner to pharmaceutical, biotech, academic and non-profit organizations all over the […]
Gilde Healthcare sells its stake in Zetacom to facilitate a merger with Detron
The Private Equity fund of Gilde Healthcare, the leading European specialist healthcare investor, has reached an agreement to sell its majority stake in Zetacom to Avedon Capital, a leading mid-market private equity firm in the Benelux and DACH-region. Avedon will merge the company with Detron, an independent IT service provider. The transaction is still subject […]
Gilde Healthcare neemt Sanquin Reagents over
Investeert in schaalvergroting en ontwikkeling nieuwe medische tests
Gilde Healthcare bolsters its Private Equity team in Frankfurt office
Dutch sector specialist Gilde Healthcare announces two new hires to its private equity team in Germany, following the recent close of its new €518m lower mid-market fund Gilde Healthcare Private Equity IV. With the recruitment of Martin von Berg as Investment Manager and Lara Hilgert as Investment...
Gilde Healthcare company Zetacom acquires communication specialist Ooperon
Dutch communication system integrator Zetacom B.V. announced the acquisition of communication specialist Ooperon B.V.
Gilde Healthcare invests in German precision surgical instruments contract manufacturer Chr. Diener
Leading contract manufacturer of highly complex, customer-specific, surgical instruments partners with Gilde Healthcare to further build on the company’s 122-year heritage.
Gilde Healthcare portfolio company Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development
Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions and specifically solutions for targeted radiopharmaceuticals.
Gilde Healthcare haalt meer dan €500 miljoen op voor private equity investeringen in zorgbedrijven
Gilde Healthcare Private Equity IV haalt €517 miljoen op voor investeringen in zorgbedrijven in het lower mid-market segment Gilde Healthcare heeft in twee jaar €933 miljoen opgehaald voor haar private equity en venture&growth fondsen Investeringsmaatschappij Gilde Healthcare kondigt vandaag de eerste en definitieve sluiting aan van Gilde...